Lv41
560 积分 2024-05-13 加入
P3.13D.01 Proteomic Characterization of Antibody Drug Conjugate Target Expression Profiles in Small Cell Lung Cancer (SCLC)
2天前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
2天前
已完结
Homogeneous multi-payload antibody–drug conjugates
4天前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
4天前
已完结
Biomarker Landscape of Antibody Drug Conjugates (ADCs) and Bispecific Antibodies in Clinical Trials for Lung Cancer
14天前
已完结
Antibody-Drug Conjugates in Breast Cancer: Toward a Molecular Perspective Into Clinical Practice
15天前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
17天前
已完结
Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy Study
20天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
25天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
28天前
已完结
皖公网安备34019202002308
